Cancer test would pinpoint high-risk women

Tuesday, 22 March, 2016
An EU-funded project is developing a single genetic test that would indicate an individual woman's risk of developing breast, cervical, womb or ovarian cancer - potentially saving lives.

The proposed test, being developed by the FORECEE project, would enable women at high risk to take preventative actions earlier, or to halt progression of incipient cancer before it becomes invasive. The test would also spare women with a low risk of developing these cancers from unnecessary screening tests.

Read more

Project: 
Female cancer prediction using cervical omics to individualise screening and prevention
Project Acronym: 
FORECEE
Article
#H2020